p53 in mammary ductal carcinoma in situ, mutations in high-grade lesions only?

Journal of the National Cancer Institute

Volumn 93, Issue 9, 2001, Pages 666-667

  Simpson, Jean F ^a   Page, David L ^a   Edgerton, Mary E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

BREAST CARCINOMA; BREAST DUCT; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CARCINOMA IN SITU; CONTROLLED STUDY; EDITORIAL; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

EID: 0035795583     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.9.666     Document Type: Editorial

References (14)

1. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
2. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ
3. Outcomes and factors impacting local recurrence of ductal carcinoma in situ
4. The influence of margin width on local control of ductal carcinoma in situ of the breast
5. p53 mutations and expression in breast carcinoma in situ
6. p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast
7. P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers
8. The p53 tumor suppressor gene in ductal carcinoma in situ of the breast
9. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias
10. p53 mutations are confined to comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data
11. High density synthetic oligonucleotide arrays
12. Expression profiling using cDNA microarrays
13. Ductal carcinoma in situ of the breast: Reproducibility of histological subtype analysis
14. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions